Intelligence Platform
Patents
Browse 595 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9987242
Treatment of Levodopa-induced Dyskinesias
granted patentUS 9981968
Substituted pyrrolo[2,3-d]pyrimidines for the treatment of cancer and proliferative disord
granted patentUS 9980992
Lactobacillus with decreased lipoteichoic acid to reduce inflammatory responses
granted patentUS 9980976
Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of gluc
granted patentUS 9968642
Compositions and methods for treatment of pain
granted patentUS 9962448
Compounds and methods for targeted immune system delivery
granted patentUS 9951014
Mammalian and bacterial nitric oxide synthase inhibitors
granted patentUS 9931333
Compositions and methods for treating or preventing atrial fibrillation
granted patentUS 9931418
Compositions for the delivery of RNA and drugs into cells
granted patentUS 9925213
Nylon-3 co-polymers and synthetic lung surfactant compositions containing same
granted patentUS 9907479
Contribution of oxidative stress to AF electrograms
granted patentUS 9897595
Compositions and methods for the detection of zinc
granted patentUS 9890117
Benzamide compounds and related methods of use
granted patentUS 9889209
Nanoconjugates able to cross the blood-brain barrier
granted patentUS 9878996
2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric ox
granted patentUS 9878984
Anti-cancer compounds
granted patentUS 9862761
Composition and method for preventing or treating a tauopathy
granted patentUS 9856231
Tetrahydrothiophene-based GABA aminotransferase inactivators
granted patentUS 9844600
Injectable thermoresponsive polyelectrolytes
granted patentUS 9844562
Polyvalent RNA-nanoparticle compositions
granted patentUS 9839625
Inhibition of cancer cell motility
granted patentUS 9802946
NMDA receptor modulators and uses thereof
granted patentUS 9801952
Magnetic nanostructures as theranostic agents
granted patentUS 9802942
Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for
granted